Beta Bionics, Inc. (BBNX) vs QuidelOrtho Corporation (QDEL)
A side-by-side comparison of Beta Bionics, Inc. and QuidelOrtho Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BBNX
Beta Bionics, Inc.
$18.72HealthcareDelayed quote: Oct 6, 2026, 12:30 PM EDT
QDEL
QuidelOrtho Corporation
$12.51HealthcareDelayed quote: Oct 6, 2026, 12:30 PM EDT
Total return — BBNX vs QDEL
growth of $100 · dividends reinvested · last 2yBBNX -19.8% (-10.4%/yr)QDEL -72.6% (-47.6%/yr)BBNX compounded faster over this window
BBNX QDEL
BBNX vs QDEL: by the numbers
- •QDEL is the larger company ($853M vs $842M market cap).
- •Both run net losses; QDEL's is the smaller (-39.20% vs -61.32% net margin).
Metrics side by side
Valuation
| Metric | BBNX | QDEL |
|---|---|---|
| Forward P/E | N/A | 16.19 |
| P/S ratio | 7.08 | 0.32 |
| P/B ratio | 3.29 | 0.48 |
Profitability
| Metric | BBNX | QDEL |
|---|---|---|
| Gross margin | 58.31% | 44.60% |
| Operating margin | -69.75% | -30.67% |
| Net margin | -61.32% | -39.20% |
| ROE | -28.46% | -59.07% |
| ROIC | -31.17% | -16.05% |
Growth (annualized)
| Metric | BBNX | QDEL |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 7.14% |
| Total return CAGR (5Y) | N/A | -38.12% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.